These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Contractile effect of TRPA1 receptor agonists in the isolated mouse intestine. Penuelas A, Tashima K, Tsuchiya S, Matsumoto K, Nakamura T, Horie S, Yano S. Eur J Pharmacol; 2007 Dec 08; 576(1-3):143-50. PubMed ID: 17825279 [Abstract] [Full Text] [Related]
4. Triphenylphosphine oxide is a potent and selective inhibitor of the transient receptor potential melastatin-5 ion channel. Palmer RK, Atwal K, Bakaj I, Carlucci-Derbyshire S, Buber MT, Cerne R, Cortés RY, Devantier HR, Jorgensen V, Pawlyk A, Lee SP, Sprous DG, Zhang Z, Bryant R. Assay Drug Dev Technol; 2010 Dec 08; 8(6):703-13. PubMed ID: 21158685 [Abstract] [Full Text] [Related]
9. Stimulation of the chemosensory TRPA1 cation channel by volatile toxic substances promotes cell survival of small cell lung cancer cells. Schaefer EA, Stohr S, Meister M, Aigner A, Gudermann T, Buech TR. Biochem Pharmacol; 2013 Feb 01; 85(3):426-38. PubMed ID: 23219522 [Abstract] [Full Text] [Related]
10. NPPB structure-specifically activates TRPA1 channels. Liu K, Samuel M, Ho M, Harrison RK, Paslay JW. Biochem Pharmacol; 2010 Jul 01; 80(1):113-21. PubMed ID: 20226176 [Abstract] [Full Text] [Related]
16. A novel 3-(4,5-diphenyl-1,3-oxazol-2-yl)propanal oxime compound is a potent Transient Receptor Potential Ankyrin 1 and Vanilloid 1 (TRPA1 and V1) receptor antagonist. Payrits M, Sághy É, Mátyus P, Czompa A, Ludmerczki R, Deme R, Sándor Z, Helyes Z, Szőke É. Neuroscience; 2016 Jun 02; 324():151-62. PubMed ID: 26930003 [Abstract] [Full Text] [Related]